Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kosuke Takano

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Annals of Hematology|December 20, 2024
Whole exome sequencing analysis of a patient with myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions with ETV6::LYN fusion geneRika Hosoba, Suguru Fukuhara, Yasunori Kogure, et al.
Annals of Hematology|March 20, 2025
Proinflammatory and prothrombotic conditions in JAK2V617F-positive MPN: a case of Lemierre's syndrome in essential thrombocythemiaTakuya Izumi-Tamura, Kosuke Takano, Shigeki Nagao, et al.
International Journal of Hematology|October 17, 2017
Sudden blast phase in chronic myeloid leukemia developed during nilotinib therapy after major molecular response was achievedYosuke Okada, Ken Sato, Shinichi Kobayashi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 7, 2020
[Bendamustine and rituximab combination therapy for recurrent indolent B-cell lymphomas: a retrospective single-institution study]Masahiro Teramoto, Takehiro Sone, Kohei Takada, et al.
Haematologica|June 20, 2024
Decision analysis for transplant candidates with primary myelofibrosis in the ruxolitinib eraYosuke Okada, Hideki Nakasone, Shunto Kawamura, et al.
Cytotherapy|October 25, 2024
Female-to-male allogeneic transplantation affects outcomes differently according to the type of haplo-transplantationMasaharu Tamaki, Shunto Kawamura, Kosuke Takano, et al.
Clinical Immunology (Orlando, Fla.)|March 11, 2026
Relationship between repertoire diversity of B cell receptor immunoglobulin G heavy chain and infectious complications caused by encapsulated bacteria after allogeneic hematopoietic cell transplantationShun-Ichi Kimura, Kazuaki Kameda, Hideki Nakasone, et al.
Leukemia & Lymphoma|May 12, 2026
Systemic corticosteroid-free beclomethasone dipropionate monotherapy for mild acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantationNozomu Yoshino, Shun-Ichi Kimura, Natsuo Shiraishi, et al.
Transplantation and Cellular Therapy|May 28, 2026
The impact of female-to-male allogeneic hematopoietic cell transplantation on survival outcomes varies by recipient ageKosuke Takano, Masaharu Tamaki, Yoshitaka Inoue, et al.
Blood|July 5, 2019
Increased SLAMF7<sup>high</sup> monocytes in myelofibrosis patients harboring <i>JAK2</i>V617F provide a therapeutic target of elotuzumabTakaaki Maekawa, Shoichiro Kato, Toshikuni Kawamura, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Annals of Hematology|December 20, 2024
Whole exome sequencing analysis of a patient with myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions with ETV6::LYN fusion geneRika Hosoba, Suguru Fukuhara, Yasunori Kogure, et al.
Annals of Hematology|March 20, 2025
Proinflammatory and prothrombotic conditions in JAK2V617F-positive MPN: a case of Lemierre's syndrome in essential thrombocythemiaTakuya Izumi-Tamura, Kosuke Takano, Shigeki Nagao, et al.
International Journal of Hematology|October 17, 2017
Sudden blast phase in chronic myeloid leukemia developed during nilotinib therapy after major molecular response was achievedYosuke Okada, Ken Sato, Shinichi Kobayashi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 7, 2020
[Bendamustine and rituximab combination therapy for recurrent indolent B-cell lymphomas: a retrospective single-institution study]Masahiro Teramoto, Takehiro Sone, Kohei Takada, et al.
Haematologica|June 20, 2024
Decision analysis for transplant candidates with primary myelofibrosis in the ruxolitinib eraYosuke Okada, Hideki Nakasone, Shunto Kawamura, et al.
Cytotherapy|October 25, 2024
Female-to-male allogeneic transplantation affects outcomes differently according to the type of haplo-transplantationMasaharu Tamaki, Shunto Kawamura, Kosuke Takano, et al.
Clinical Immunology (Orlando, Fla.)|March 11, 2026
Relationship between repertoire diversity of B cell receptor immunoglobulin G heavy chain and infectious complications caused by encapsulated bacteria after allogeneic hematopoietic cell transplantationShun-Ichi Kimura, Kazuaki Kameda, Hideki Nakasone, et al.
Leukemia & Lymphoma|May 12, 2026
Systemic corticosteroid-free beclomethasone dipropionate monotherapy for mild acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantationNozomu Yoshino, Shun-Ichi Kimura, Natsuo Shiraishi, et al.
Transplantation and Cellular Therapy|May 28, 2026
The impact of female-to-male allogeneic hematopoietic cell transplantation on survival outcomes varies by recipient ageKosuke Takano, Masaharu Tamaki, Yoshitaka Inoue, et al.
Blood|July 5, 2019
Increased SLAMF7<sup>high</sup> monocytes in myelofibrosis patients harboring <i>JAK2</i>V617F provide a therapeutic target of elotuzumabTakaaki Maekawa, Shoichiro Kato, Toshikuni Kawamura, et al.
Pageof 3